{"entity":{"type":"insider","cik":"0001837016","url":"/insider/0001837016","json_url":"/insider/0001837016.json","name":"Li Dean Y","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":7,"first":"2021-11-19","last":"2026-02-10","span_basis":"filed_date"},"name_variants":[{"name":"Li Dean Y","source":"filing","n_filings":7,"first_seen":"2021-11-19","last_seen":"2026-02-10"}],"transactions":[{"id":5794005,"accession":"0000310158-26-000050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000310158-26-000050","line_url":"/filing/0000310158-26-000050#line-1","is_derivative":false,"issuer_cik":"0000310158","issuer_name":"Merck & Co., Inc.","issuer_ticker":"MRK","issuer_name_source":null,"issuer_url":"/issuer/0000310158","owner_cik":"0001837016","owner_name":"Li Dean Y","owner_display_name":"Li Dean Y","owner_url":"/insider/0001837016","role":"Officer (Executive VP & President, MRL)","role_mark":"O","role_mark_label":"Officer (Executive VP & President, MRL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP & President, MRL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10235.0,"shares_display":"10,235","price_per_share":117.5226,"price_display":"117.52","price_state":"stated","total_value":1202843.811,"total_display":"1,202,843.81","total_whole":"1,202,844","shares_owned_after":92035.05,"shares_owned_after_display":"92,035.05","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-10","filed_date":"2026-02-10","scope":"insider"},{"id":6163163,"accession":"0000310158-26-000036","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000310158-26-000036","line_url":"/filing/0000310158-26-000036#line-2","is_derivative":false,"issuer_cik":"0000310158","issuer_name":"Merck & Co., Inc.","issuer_ticker":"MRK","issuer_name_source":null,"issuer_url":"/issuer/0000310158","owner_cik":"0001837016","owner_name":"Li Dean Y","owner_display_name":"Li Dean Y","owner_url":"/insider/0001837016","role":"Officer (Executive VP & President, MRL)","role_mark":"O","role_mark_label":"Officer (Executive VP & President, MRL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP & President, MRL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15087.0,"shares_display":"15,087","price_per_share":118.7661,"price_display":"118.77","price_state":"stated","total_value":1791824.1507,"total_display":"1,791,824.15","total_whole":"1,791,824","shares_owned_after":102270.05,"shares_owned_after_display":"102,270.05","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-04","filed_date":"2026-02-06","scope":"insider"},{"id":2307165,"accession":"0001127602-24-004438","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-24-004438","line_url":"/filing/0001127602-24-004438#line-2","is_derivative":false,"issuer_cik":"0000310158","issuer_name":"Merck & Co., Inc.","issuer_ticker":"MRK","issuer_name_source":null,"issuer_url":"/issuer/0000310158","owner_cik":"0001837016","owner_name":"Li Dean Y","owner_display_name":"Li Dean Y","owner_url":"/insider/0001837016","role":"Officer (Executive VP & President, MRL)","role_mark":"O","role_mark_label":"Officer (Executive VP & President, MRL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP & President, MRL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14702.0,"shares_display":"14,702","price_per_share":125.4988,"price_display":"125.50","price_state":"stated","total_value":1845083.3576,"total_display":"1,845,083.36","total_whole":"1,845,083","shares_owned_after":46242.37,"shares_owned_after_display":"46,242.37","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-09","filed_date":"2024-02-12","scope":"insider"},{"id":2842769,"accession":"0001209191-24-001486","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-001486","line_url":"/filing/0001209191-24-001486","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001837016","owner_name":"Li Dean Y","owner_display_name":"Li Dean Y","owner_url":"/insider/0001837016","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29000.0,"shares_display":"29,000","price_per_share":13.662545806896551,"price_display":"13.66","price_state":"stated","total_value":396213.8284,"total_display":"396,213.83","total_whole":"396,214","shares_owned_after":421962.0,"shares_owned_after_display":"421,962","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-09","filed_date":"2024-01-11","scope":"insider","n_lines":2},{"id":4958447,"accession":"0001209191-21-068918","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-068918","line_url":"/filing/0001209191-21-068918","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001837016","owner_name":"Li Dean Y","owner_display_name":"Li Dean Y","owner_url":"/insider/0001837016","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15900.0,"shares_display":"15,900","price_per_share":20.479898742138364,"price_display":"20.48","price_state":"stated","total_value":325630.39,"total_display":"325,630.39","total_whole":"325,630","shares_owned_after":1316000.0,"shares_owned_after_display":"1,316,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-07","filed_date":"2021-12-09","scope":"insider","n_lines":2},{"id":9271641,"accession":"0001209191-21-068911","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-068911","line_url":"/filing/0001209191-21-068911#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001837016","owner_name":"Li Dean Y","owner_display_name":"Li Dean Y","owner_url":"/insider/0001837016","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13474.0,"shares_display":"13,474","price_per_share":20.2038,"price_display":"20.20","price_state":"stated","total_value":272226.0012,"total_display":"272,226.00","total_whole":"272,226","shares_owned_after":1330900.0,"shares_owned_after_display":"1,330,900","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-19","filed_date":"2021-12-09","scope":"insider"},{"id":4386828,"accession":"0001209191-21-065896","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-065896","line_url":"/filing/0001209191-21-065896#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001837016","owner_name":"Li Dean Y","owner_display_name":"Li Dean Y","owner_url":"/insider/0001837016","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13474.0,"shares_display":"13,474","price_per_share":20.2038,"price_display":"20.20","price_state":"stated","total_value":272226.0012,"total_display":"272,226.00","total_whole":"272,226","shares_owned_after":578163.0,"shares_owned_after_display":"578,163","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-19","filed_date":"2021-11-19","scope":"insider"},{"id":9271640,"accession":"0001209191-21-068911","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-068911","line_url":"/filing/0001209191-21-068911#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001837016","owner_name":"Li Dean Y","owner_display_name":"Li Dean Y","owner_url":"/insider/0001837016","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5626.0,"shares_display":"5,626","price_per_share":20.0384,"price_display":"20.04","price_state":"stated","total_value":112736.0384,"total_display":"112,736.04","total_whole":"112,736","shares_owned_after":1344374.0,"shares_owned_after_display":"1,344,374","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-17","filed_date":"2021-12-09","scope":"insider"},{"id":4386824,"accession":"0001209191-21-065896","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-065896","line_url":"/filing/0001209191-21-065896#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001837016","owner_name":"Li Dean Y","owner_display_name":"Li Dean Y","owner_url":"/insider/0001837016","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5626.0,"shares_display":"5,626","price_per_share":20.0384,"price_display":"20.04","price_state":"stated","total_value":112736.0384,"total_display":"112,736.04","total_whole":"112,736","shares_owned_after":591637.0,"shares_owned_after_display":"591,637","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-17","filed_date":"2021-11-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000310158","name":"Merck & Co., Inc.","url":"/issuer/0000310158","role":"Officer (Executive VP & President, MRL)","n_filings":3,"first_seen":"2024-02-12","last_seen":"2026-02-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001601830","name":"RECURSION PHARMACEUTICALS, INC.","url":"/issuer/0001601830","role":"Director","n_filings":4,"first_seen":"2021-11-19","last_seen":"2024-01-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001837016","retrieved_at":"2026-08-27T14:50:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}